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Introduction
The increasing prevalence of metabolic disorders in our modern society represents a serious medical and economic challenge for the future [1] . A sedentary lifestyle and a low metabolic efficiency substantially contribute to the development of such diseases [1; 2] . Inversely, regular exercise ameliorates or partially prevents these conditions.
The peroxisome proliferator-activated receptor γ coactivator 1α largely mediates the adaptive effects of exercise in skeletal muscle [3; 4; 5] . PGC-1α is a transcriptional coactivator and is known to promote the expression of several transcription factors, which it subsequently coactivates [6] . An endurance trained status can be pheno-copied by muscle-specific overexpression of PGC-1α, even in the absence of physical activity [7; 8; 9] . PGC-1α induces mitochondrial biogenesis, improves oxygen supply to muscle by promoting angiogenesis [10] , increases peak oxygen consumption, and endurance capacity [8] . Moreover, PGC-1α drives fiber-type switching from fast, glycolytic towards slow, oxidative fibers [7] . Most importantly, PGC-1α promotes lipid and glucose provision and enhances oxidative metabolism [3; 11] .
A reduction in metabolic efficiency is associated with insulin resistance in rodents and humans [12] . Regular physical activity is thus believed to exert a beneficial effect by elevating the metabolic capacity [13] . However, a careful regulation of this process seems important since excessive or dysbalanced oxidative metabolism impairs insulin sensitivity [14] . For example, acylcarnitines are generated when the amount of lipids fluxed into β-oxidation exceeds the capacity of the Krebs cycle and/or oxidative phosphorylation (OXPHOS) [14] . These detrimental lipid species are subsequently released into the circulation and contribute to the development of insulin resistance. Similarly, the proton gradient that generates the mitochondrial membrane potential is a potential source of reactive oxygen species (ROS), which are also implicated in the etiology of insulin resistance [15] . Currently, it is unresolved whether the induction of oxidative metabolism through PGC-1α leads to generation of such metabolites in skeletal muscle in mice fed a normal chow diet.
We now investigated the impact of elevated oxidative metabolism driven by PGC-1α on the production of acylcarnitines and/or ROS in the extensor digitorum longus (EDL) muscle, on whole body glucose homeostasis and on PI3K activity as an early marker of skeletal muscle insulin sensitivity. Finally, we describe the molecular mechanisms that fine-tune oxidative metabolism and increase metabolic flexibility upon ectopic expression of PGC-1.
Materials and Methods

Animals
Muscle-specific PGC-1α transgenic mice (MPGC-1α TG) [7] and control littermates were maintained in a conventional facility with a fixed 12-h light/dark cycle on a commercial pellet chow diet and free access to tap water. Studies were performed according to criteria outlined for the care and use of laboratory animals and with approval of the Swiss authorities.
RNA extraction and RT-PCR
Frozen tissues were homogenized under liquid nitrogen and total RNA was isolated using Trizol reagent (Invitrogen). RNA concentrations were adjusted and reverse transcription was carried out using random hexamer primers (Promega). Real-time PCR analysis (Power SYBR Green Master Mix, Applied Biosystems) was performed using the ABI Prism 7000 Sequence Detector. Relative expression levels for each gene of interest were calculated with the Ct method and normalized to the expression of the Tata box binding protein (TBP). Mitochondrial DNA content was quantified by determining the ratio of mitochondrial cytochrome c oxidase 2 (Cox2) to nuclear intron of β-globin by RT-PCR of isolated DNA.
Lipid oxidation
Palmitate oxidation was measured as described by Dyck et al [16] . Radioactivity in the water phase was quantified using a Beckman liquid scintillation counter. All values were corrected for initial tissue weight and expressed as fold change compared to control animals.
Muscle ROS
To monitor intracellular generation of ROS, 2′,7′-dichlorofluorescein diacetate (H 2 DCFDA) (Sigma) was used. EDL muscles were harvested in cold-buffered medium (5 mmol/l HEPES in PBS) and immediately frozen in liquid nitrogen. After rapid thawing, medium was discarded. Samples were exposed to 8 μmol/l H 2 DCFDA dissolved in 400 μl fresh medium and were incubated at 37°C for 30 min under agitation. Medium was then removed, samples were homogenized and further incubated in lysis buffer (0.1% SDS, Tris-HCl, pH 7.4). Samples were centrifuged at 14'000rpm. Supernatants were collected and subjected to fluorescence analysis at 520 nm under excitation at 485 nm using a microplate reader. Dichlorofluorescein fluorescence corresponds to the ROS production generated during the ex vivo sample incubation.
Acylcarnitine determination
Acylcarnitines were extracted from dried blood spots using methanol containing eight isotopically labeled internal standards (Cambridge Isotopes Laboratories) and analyzed without prior sample derivatization. Precursor ions of m/z 85 in the mass range of m/z 150 to 450 are acquired on a PerkinElmer API 365 LC-ESI-MS/MS instrument.
Glucose and insulin tolerance tests
Animals were fasted for 16 h and 6 h before i.p. injection of 2 g/kg glucose and 0.8 U/kg insulin, respectively. Blood was obtained at intervals of 15 minutes from the tail vein, and glucose levels were determined using a standard glucometer.
PI3K activity
Muscles were dissected, immediately frozen in liquid nitrogen and homogenized under liquid nitrogen. IRS-1 associated PI3K activity was assessed as previously described [17; 18] .
Mitochondrial mass and membrane potential
Myoblasts isolated from MPGC-1α TG mice and control littermates were permitted to fuse into multinucleated myotubes. Mitochondrial mass and membrane potential were measured in myotubes using Mitotracker Green (MTG; Molecular Probes) and Tetramethylrhodamine ethyl ester (TMRE; Molecular Probes). In brief, cells were incubated with differentiation media containing 100nM MTG or 100 nM TMRE for 20 min at 37°C in a humidified atmosphere of 5% CO 2 . After 20 min, cells were washed three times with PBS, and a microplate reader was used to measure MTG or TMRE fluorescence (excitation 490 or 549 nm, emission 516 or 574 nm, respectively). Fluorescent values for the mitochondrial membrane potential were corrected for mitochondrial mass.
Data analysis and statistics
All data are presented as means ± SE. The data were analyzed by 2-tailed, unpaired Student's t test or Mann-Whitney test when the difference between the two SDs was significantly different. Levels of significance are indicated as follows: *** p<0.001, ** p< 0.01, * p< 0.05.
Results
Increased mitochondrial biogenesis and elevated mitochondrial DNA content in EDL muscle of MPGC-1α TG mice PGC-1α gene expression in EDL muscle is ~9 times higher in MPGC-1α TG mice than in controls (P < 0.001) and no potentially compensatory changes in the expression of PGC-1β or PGC-1-related coactivator are observed ( Figure 1A ). Consequently, mRNA levels of the mitochondrial regulators estrogen-related receptor α and mitochondrial transcription factor A as well as the mitochondrial proteins NADH-ubiquinone oxidoreductase Fe-S protein 1, NADH-ubiquinone oxidoreductase flavoprotein 2, cytochrome c and medium chain acyl-coA dehydrogenase are significantly increased in transgenic animals ( Figure 1B ). Furthermore, MPGC-1α TG mice display elevated mitochondrial DNA content (+64% (P<0.001)) ( Figure  1C ) and increased mitochondrial mass ( Figure 1D ).
Enhanced lipid oxidation is in balance with the Krebs cycle in MPGC-1α TG mice
We next examined whether these mice subsequently show altered mitochondrial lipid metabolism in EDL. Expression of genes involved in the activation of fatty acid β-oxidation (CPT-1b and MCD) are up-regulated in MPGC-1α TG mice (+237% and +169% respectively); reaching statistical significance only for CPT-1b (P<0.01) ( Figure 2A) . Surprisingly, ACC2, which is implicated in the inhibition of β-oxidation, is similarly induced (+189%, P<0.01) (Figure 2A) . Nevertheless, the overall β-oxidation rate is increased in MPGC-1α TG mice by +62% (P<0.05) ( Figure 2B ). To evaluate downstream events of lipid oxidation, we determined mRNA expression of citrate synthase. Our results show that mRNA levels of citrate synthase are significantly higher in MPGC-1α TG mice than in controls (+299%, P<0.001) ( Figure 2C ). Excessive or dysbalanced lipid oxidation contributes to skeletal muscle insulin resistance by increasing acylcarnitines production and secretion [14] . We thus tested whether the elevated lipid oxidation in MPGC-1α TG mice is associated with the production of such detrimental metabolites by LC-ESI-MS/MS. This technique is very sensitive and even enables the detection of mild defects in lipid oxidation. No significant changes between MPGC-1α TG and control animals were found for any of these carnitine esters in the circulation ( Figure 2D ).
Elevated oxidative phosphorylation, but unchanged ROS generation in MPGC-1α TG mice
Increased fatty acid oxidation and Krebs cycle activity ultimately feed into the mitochondrial oxidative phosphorylation (OXPHOS) for ATP production. Accordingly, genes encoding different subunits of the OXPHOS system are elevated in MPGC-1α TG animals ( Figure 3A) . Interestingly, expression of the uncoupling protein 3 (UCP3) is likewise increased ( Figure  3A ). UCP3 might dissipate the proton gradient in the mitochondria and thereby reduce the membrane potential and ATP synthesis. However, the net effect of these seemingly counteracting processes is an increase in membrane potential by +4% (P<0.05) ( Figure 3B ).
To study the impact of an elevated membrane potential on ROS production, we evaluated mRNA expression of genes implicated in ROS production and detoxification. Mitochondrialencoded superoxide dismutase 2 (SOD2) is increased in MPGC-1α TG mice (+127%, P<0.01), whereas nuclear-encoded SOD1 is decreased by -27% (P<0.05) ( Figure 3C) . Furthermore, the expression of genes involved in H 2 O 2 detoxification, namely catalase, glutathione reductase and glutathione peroxidase, does not differ between MPGC-1α TG and control mice ( Figure 3C ). As a consequence, overall H 2 O 2 production is unaltered in MPGC-1α TG mice suggesting a tightly regulated balance between OXPHOS and ROS metabolism ( Figure 3D ).
Normal glucose homeostasis despite enhanced muscle oxidative metabolism in MPGC-1α TG mice
The ability of MPGC-1α TG and control mice to deal with an acute glucose load was assessed by a glucose tolerance test. Both genotypes show similar glucose excursion curves ( Figure  4A ). Insulin tolerance tests were used to determine whether systemic insulin sensitivity is altered in MPGC-1α TG mice. The capacities of MPGC-1α TG and control mice to regulate blood glucose levels after a bolus of insulin are indistinguishable ( Figure 4B ). Finally, IRS-1 associated PI3K activity, which is a very early marker for defects in glucose homeostasis, does not differ significantly between the two genotypes ( Figure 4C ).
Discussion
The increasing prevalence of metabolic disorders poses a major public health problem [1] and a sedentary lifestyle strongly promotes the development of such metabolic diseases [2] . Although most people are aware of the necessity of adequate physical activity, many are unable or unwilling to achieve the level that is required to elicit health benefits. The development of drugs that mimic the plastic changes elicited by exercise thus constitutes an intriguing pharmacological approach to this problem [13; 19] . PGC-1α is an attractive target for such interventions because this protein is central to endurance exercise adaptation and by itself is sufficient to induce a trained phenotype along with an elevated metabolic capacity [3; 4; 5; 13]. Moreover, known experimental "exercise mimetics", including activators for AMPdependent protein kinase, at least in part act through PGC-1α [20] . Importantly however, when oxidative metabolism is promoted in excess, or when only individual oxidative pathways are increased without simultaneous up-regulation of subsequent steps, adverse effects on metabolic functions occur [14; 15] .
We now show that PGC-1α coordinately induces genes that promote lipid oxidation (CPT-1b and MCD), Krebs cycle (citrate synthase) and OXPHOS (subunits of complexes I-V) and thereby couples all major oxidative steps in EDL muscle. Intriguingly, we found that PGC-1α not only controls the expression of positive, but also of negative regulators of fatty acid oxidation and OXPHOS. Thus, the levels of ACC2, an inhibitior of lipid oxidation, and of UCP3, which uncouples mitochondria and thereby reduces OXPHOS, are both elevated in the transgenic animals. Importantly, while the overall gene expression pattern is ambiguous, the net rates are nonetheless clearly showing an increased oxidation of fatty acids and an elevated mitochondrial membrane potential. Therefore, our findings imply that the increased β-oxidation and the subsequent Krebs cycle and OXPHOS are tightly regulated and balanced by PGC-1α in EDL muscle ( Figure 4D ). The concomitant induction of both positive and negative regulators of fatty acid oxidation and OXPHOS through PGC-1α boosts metabolic flexibility and restrains excessive oxidation.
As a consequence of the complex gene expression controlled by PGC-1α, detrimental side products of β-oxidation or increased ROS, which both have been linked to the etiology of insulin resistance [14; 15] , are not observed in our animal model with ectopically expressed PGC-1α in muscle despite significantly higher oxidative activity. A relationship between acylcarnitines and insulin resistance has recently been established in rodents and type 2 diabetic patients [14; 21; 22] . Elevated acylcarnitines were reported in blood and skeletal muscle from insulin-resistant rats, but there was no increase observed in the liver, suggesting that blood acylcarnitines mainly originated from muscle [14] . In the human study, long, shortand medium-chain acylcarnitines increased in diabetic patients compared to lean individuals [21] . The accumulation of short-chain acylcarnitines, which represent late degradation products of lipid catabolism, is suggestive of inefficient fatty acid oxidation or poor coupling between lipid oxidation and OXPHOS in diabetic subjects [21] . The acylcarnitine profile in our study does not reveal any chain-length dependent alterations between wild-type and transgenic animals. We even observe a trend towards lower levels of short-chain acylcarnitines. This is consistent with an improved oxidative capacity and tight coupling of β-oxidation, Krebs cycle and OXPHOS. Even when further subdivided into different lipid classes, such as saturated, mono-or polyunsaturated acylcarnitines, no differences between control and transgenic animals are detectable. This detailed inspection might be important, as analogous to fatty acids, saturated species of acylcarnitines might exert a more detrimental effect on insulin sensitivity than mono-or polyunsaturated species. The exact connection between acylcarnitines and insulin sensitivity is a future issue that needs to be addressed. A possible mechanism might involve the induction of NFκB through acycarnitines as previously demonstrated in vitro [23] . Finally, while an effect of PGC-1α on ROS detoxification and mitochondrial uncoupling has been shown in previous studies in vitro [24; 25] , we now for the first time demonstrate unchanged levels of ROS in muscle of PGC-1α transgenic mice compared to wild-type controls. These findings suggest a tight balance between mitochondrial activity, a major source of ROS, and ROS detoxification in muscle with elevated PGC-1α. This balance might be achieved by limited production of ROS via UCP3-mediated mitochondrial uncoupling in combination with enhanced ROS detoxification, e.g. through elevated SOD2.
Although we focused our studies on EDL muscle, PGC-1α is obviously elevated in all skeletal muscles in our experimental mouse model. Interestingly, the enhancement of muscle oxidative metabolism in skeletal muscle does not influence whole body glucose homoeostasis as glucose and insulin tolerance remain normal in the transgenic mice fed a normal chow diet. The possibility arises, however, that alterations in insulin sensitivity occur in skeletal muscle, but that compensatory mechanisms in other tissues restore whole body glucose homeostasis. Thus, to directly determine insulin sensitivity in skeletal muscle, PI3K, a key molecule in insulin signaling and an early marker for insulin resistance, was investigated as PI3K activity is already impaired in the pre-diabetic state [17] . We demonstrate that PI3K activity in EDL muscle is similar in wild type and transgenic animals, corroborating further that peripheral insulin sensitivity in skeletal muscle is preserved. Intriguingly, sedentary PGC-1 musclespecific transgenic mice on a high fat diet develop insulin resistance even faster than wildtype control mice [26] . We have previously demonstrated that as part of the exercise adaptations controlled by PGC-1α, these mice have higher de-novo lipogenesis rates and thus exhibit an accumulation of intramyocellular lipids [11] . These data suggested that the use of putative exercise mimetics in sedentary individuals on a Western diet could even exacerbate pathological conditions. Our findings reported here show that without excess dietary lipids, ectopically expressed PGC-1α mediates beneficial adaptations in skeletal muscle, even in sedentary mice.
Taken together, our findings provide new insights into the molecular mechanisms by which PGC-1α coordinates oxidative metabolism. By tightly balancing lipid oxidation and mitochondrial electron transport, elevated muscle PGC-1α avoids the generation of detrimental side products that impair insulin sensitivity in mice fed a regular chow diet. Our findings imply that while induction of PGC-1α per se does not improve insulin sensitivity in this experimental context, this transcriptional coactivator increases the metabolic flexibility of skeletal muscle. 
